相关实验视频

Updated: Sep 16, 2025

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

针对Noonan综合征和相关疾病患者复杂淋巴异常的向治疗

Erika K S M Leenders^1,2, Vera C van den Brink^3,4, Lotte E R Kleimeier^3,4

¹Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

International journal of molecular sciences

|July 12, 2025

概括

梅克抑制剂特拉美丁尼布在治疗类似于努南综合征的RAS病变的中导淋巴异常 (CCLAs) 方面表现有前途. 婴儿对较低剂量反应良好,而老年患者的恢复速度较慢,这表明治疗疗效不同.

科学领域:

遗传学和分子生物学
儿童心脏病学儿童心脏病学
血管生物学血管生物学

背景情况:

诺南综合征 (NS) 和相关RASopathies中的淋巴病通常是由于中央导导淋巴异常 (CCLA) 的结果.
RAS/MAPK-ERK通路对于淋巴血管生成至关重要,使其成为治疗点.

研究的目的:

评估MEK抑制剂特拉美丁尼治疗在患有NS类RAS和CCLA的患者中的临床结果.
根据患者年龄和疾病严重程度,评估特拉美丁尼的疗效.

主要方法:

一个由八名患有NS类RASopathies和CCLA的患者组成的病例系列.
对临床结果的分析,包括症状缓解和淋巴细胞表型救援.
婴儿和年龄较大的儿童/青少年之间的结果比较.

主要成果:

特拉美提尼布治疗,特别是较低剂量 (0.01毫克/千克/天) 和在婴儿早期停止治疗,有效地缓解先天性胸,并改善了淋巴细胞表型.
老年患者 (>11岁) 的反应较慢,症状恢复不完全.
个体患者对特拉美丁尼布的反应各不相同,这表明需要个性化治疗方法.

结论:

特拉美替尼布是一种潜在的治疗方法,用于严重的,耐火性CCLA在NS类RASopathies.
年龄和潜在的其他遗传或生理因素会影响治疗反应.
需要进一步的研究来确定预测治疗疗效的因素,以优化CCLA管理.

关键词:

在CCLA中,我们可以使用CCLA 诺南综合征是什么意思拉索病变 (RASopathies) 是一种拉索病变.遗传学遗传学遗传学是一个淋巴异常是一种淋巴异常.有针对性的治疗.特拉美丁尼布 (trametinib) 是一种药物.

更多相关视频

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Development of the Lymphatic System

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...